CORONARY ARTERY DISEASE / CLINICAL RESEARCH
Assessment of vitamin D levels in correlation with coronary computed tomography angiography results in a Slovak population
More details
Hide details
1
East Slovak Institute of Cardiovascular Diseases and School of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia
2
Gerontology and Geriatrics Clinic, Pavol Jozef Safarik University, Kosice, Slovakia
3
Department of Cybernetics and Artificial Intelligence, Faculty of Electrical Engineering and Informatics, Technical University of Kosice, Kosice, Slovakia
Submission date: 2024-02-06
Final revision date: 2024-05-12
Acceptance date: 2024-05-15
Online publication date: 2024-06-12
Corresponding author
Tibor Poruban
East Slovak Institute of Cardiovascular Diseases and School of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The growing interest in vitamin D deficiency as a potential contributor to coronary artery disease (CAD) has prompted increased scrutiny. Nevertheless, its status as a confirmed risk factor remains unestablished. This study seeks to explore the connection between serum vitamin D levels and CAD.
Material and methods:
Employing a cross-sectional approach, 205 patients eligible for coronary computed tomography angiography (CCTA) were chosen. Serum vitamin D levels were assessed and juxtaposed with the outcomes of CCTA, which encompassed the coronary artery calcium score (CACS), as well as the presence and severity of coronary artery involvement attributed to atherosclerotic plaques.
Results:
The average age of the participants was 61.4 ±10.8 years, and the mean serum vitamin D level was 19.6 ±10.3 ng/dl (ranging from 4.7 to 39.7 ng/dl). In total, 52.1% of the participants (n = 107) exhibited vitamin D deficiency, while 47.9% (n = 98) had no deficient levels of vitamin D. The mean serum vitamin D level was notably lower in patients with severe coronary artery disease (CAD) (p < 0.0001). According to the Spearman test, a significant negative correlation (–0.48) was identified between the serum vitamin D level and CACS (p < 0.0001). Conversely, the mean CACS in the vitamin D deficient group was significantly higher than in the insufficient and non-insufficient vitamin D groups (p < 0.0001 for both comparisons).
Conclusions:
There was a correlation between vitamin D deficiency and both CACS and the severity of coronary artery stenosis.
REFERENCES (30)
1.
Saponaro F, Saba A, Zucchi R. An update on vitamin D metabolism. Int J Mol Sci 2020; 21: 6573.
2.
Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, Strauss HW. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging 2017; 10: 582-93.
3.
Dabravolski SA, Markin AM, Andreeva ER, Eremin II, Orekhov AN, Melnichenko AA. Molecular mechanisms underlying pathological and therapeutic roles of pericytes in atherosclerosis. Int J Mol Sci 2022; 23: 11663.
4.
Carbone F, Liberale L, Libby P, Montecucco F. Vitamin D in atherosclerosis and cardiovascular events. Eur Heart J 2023; 44: 2078-94.
5.
Al-Oanzi ZH, Alenazy FO, Alhassan HH, et al. The role of vitamin D in reducing the risk of metabolic disturbances that cause cardiovascular diseases. J Cardiovasc Dev Dis 2023; 10: 209.
6.
Verdoia M, Gioscia R, Nardin M, Rognoni A, De Luca G. Low levels of vitamin D and coronary artery disease: is it time for therapy? Kardiol Pol 2022; 80: 409-16.
7.
Manousaki D, Mokry LE, Ross S, Goltzman D, Richards JB. Mendelian randomization studies do not support a role for vitamin D in coronary artery disease. Circ Cardiovasc Genet 2016; 9: 349-56.
8.
Yan X, Wei Y, Wang D, et al. Four common vitamin D receptor polymorphisms and coronary artery disease susceptibility: a trial sequential analysis. PLoS One 2022; 17: e0275368.
9.
Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ 2010; 182: 1315-9.
10.
Hussain B, Mahmood A, Flynn MG, Alexander T. Coronary artery calcium scoring in asymptomatic patients. HCA Healthc J Med 2023; 4: 341-52.
11.
Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants. Front Nutr 2023; 10: 1070808.
12.
Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr 2020; 74: 1498-513.
13.
Fronczek M, Osadnik T, Banach M. Impact of vitamin D receptor polymorphisms in selected metabolic disorders. Curr Opin Clin Nutr Metab Care 2023; 26: 316-22.
14.
Ho JS, Cannaday JJ, Barlow CE, Reinhardt DB, Wade WA, Ellis JR. Low 25-OH vitamin D levels are not associated with coronary artery calcium or obstructive stenoses. Coron Artery Dis 2015; 26: 521-5.
15.
Pál É, Ungvári Z, Benyó Z, Várbíró S. Role of vitamin D deficiency in the pathogenesis of cardiovascular and cerebrovascular diseases. Nutrients 2023; 15: 334.
16.
Sabico S, Wani K, Grant WB, Al-Daghri NM. Improved HDL cholesterol through vitamin D status correction substantially lowers 10-year atherosclerotic cardiovascular disease risk score in vitamin D-deficient Arab adults. Nutrients 2023; 15: 551.
17.
Dziedzic EA, Gąsior JS, Pawłowski M, et al. Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients. Arch Med Sci 2019; 15: 359-68.
18.
Dziedzic EA, Przychodzeń S, Dąbrowski M. The effects of vitamin D on severity of coronary artery atherosclerosis and lipid profile of cardiac patients. Arch Med Sci 2016; 12: 1199-206.
19.
Bakthavatchalam R, Bakthavatchalam S, Chandran I, et al. Association of vitamin D with risk factors for coronary artery disease. Maedica (Bucur) 2023; 18: 563-70.
20.
Dziedzic EA, Gąsior JS, Saniewski T, Dąbrowski M. Vitamin D deficiency among Polish patients with angiographically confirmed coronary heart disease. Pol Merkur Lek 2021; 49: 278-82.
21.
El Mokadem M, Boshra H, Abd El Hady Y, Abd El Hameed AS. Relationship of serum vitamin D deficiency with coronary artery disease severity using multislice CT coronary angiography. Clin Investig Arterioscler 2021; 33: 282-8.
22.
Fang A, Zhao Y, Yang P, Zhang X, Giovannucci EL. Vitamin D and human health: evidence from Mendelian randomization studies. Eur J Epidemiol 2024; 39: 467-90.
23.
Gariballa S, Al-Bluwi GSM, Yasin J. Frequency of vitamin D receptor gene polymorphisms in a population with a very high prevalence of vitamin D deficiency, obesity, diabetes and hypertension. Biomedicines 2023; 11: 1202.
24.
Farahmand MA, Daneshzad E, Fung TT, et al. What is the impact of vitamin D supplementation on glycemic control in people with type-2 diabetes: a systematic review and meta-analysis of randomized controlled trails. BMC Endocr Disord 2023; 23: 15.
25.
Huang X, Yang Y, Jiang Y, Zhou Z, Zhang J. Association between vitamin D deficiency and lipid profiles in overweight and obese adults: a systematic review and meta-analysis. BMC Public Health 2023; 23: 1653.
26.
Zittermann A, Pilz S. Vitamin D and cardiovascular disease: an update. Anticancer Res 2019; 39: 4627-35.
27.
Knežević Praveček M, Vuković-Arar Ž, Miškić B, Hadžibegović I. Vitamin D deficiency in acute coronary syndrome – clinically relevant or incidental finding? Cent Eur J Public Health 2017; 25: 185-90.
28.
Adeniyi OV, Masilela C, George JA. Prevalence of vitamin D deficiency and its association with cardiometabolic risk factors among healthcare workers in the Eastern Cape province, South Africa; cross-sectional study. Sci Rep 2024; 14: 4756.
29.
Roffe-Vazquez DN, Huerta-Delgado AS, Castillo EC, et al. Correlation of vitamin D with inflammatory cytokines, atherosclerotic parameters, and lifestyle factors in the setting of heart failure: a 12-month follow-up study. Int J Mol Sci 2019; 20: 5811.
30.
Dinca M, Serban MC, Sahebkar A, et al. Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2016; 107: 360-71.